This statistic displays the cost savings in the United States associated with using generic cardiovascular pharmaceuticals from 2004 to 2013. In 2004, over **** billion U.S. dollars were saved due to generic medication in the cardiovascular therapy area. Over the last decade, **** trillion U.S. dollars were saved through the use of generic pharmaceuticals.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
GPhA, & IMS Health. (October 30, 2014). Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 04, 2026, from /statistics/373148/use-of-generic-cardiovascular-drugs-and-cost-savings-in-the-us/
GPhA, und IMS Health. "Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars)." Chart. October 30, 2014. ÌÇÐÄÆƽâ°æ. Accessed August 04, 2026. /statistics/373148/use-of-generic-cardiovascular-drugs-and-cost-savings-in-the-us/
GPhA, IMS Health. (2014). Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 04, 2026. /statistics/373148/use-of-generic-cardiovascular-drugs-and-cost-savings-in-the-us/
GPhA, and IMS Health. "Cost Savings through Cardiovascular Generic Medicine in The United States from 2004 to 2013 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 30 Oct 2014, /statistics/373148/use-of-generic-cardiovascular-drugs-and-cost-savings-in-the-us/
GPhA & IMS Health, Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/373148/use-of-generic-cardiovascular-drugs-and-cost-savings-in-the-us/ (last visited August 04, 2026)
Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars) [Graph], GPhA, & IMS Health, October 30, 2014. [Online]. Available: /statistics/373148/use-of-generic-cardiovascular-drugs-and-cost-savings-in-the-us/
